Komen Sends Millions to Embryonic Stem Cell Research Centers
by Steven Ertelt | Washington, DC | LifeNews.com | 7/19/11 11:04 AM
The Susan G. Komen for the Cure Foundation has long upset pro-life advocates for denying the abortion-breast cancer link and sending millions to the Planned Parenthood abortion business. New information shows Komen also supporting centers engaging in embryonic stem cell research.
As LifeNews.com reported last year, Komen spokesman John Hammarley confirmed 20 of Komen’s 122 affiliates have made donations to Planned Parenthood and, in 2009, those contributions totaled $731,303. The Komen spokesman also confirmed Komen affiliates contributed about $3.3 million to the abortion business from 2004-2009.
Now, Karen Malec of the Coalition on Abortion/Breast Cancer has spent time examining Komen’s 990 Forms for the IRS for 2010 and she found that Komen has active relationships with at least five research groups or educational facilities that engage in embryonic stem cell research, which requires the destruction of unborn children in their earliest days for stem cells that have yet to help any patients.
Komen is careful in its documents to state that none of the funds directly support embryonic stem cell research, saying in its Group Return for 2010 under a section entitled “Grant Statement” that “While Komen affiliates do not fund research grants directly, a portion of the funds raised by every Komen affiliate (approximately 25%) go to support the research and training grants program at Komen’s International Headquarters.”
The return shows donations from Komen totaling $3.75 million to Johns Hopkins University School of Medicine, $4.5 million to the University of Kansas Medical Center, $1 million to the U.S. National Cancer Institute, $1 million to the Society for Women’s Health Research, and $600,000 to Yale University.
Looking at those institutions, Yale not only engages in embryonic stem cell research but, in 2006, came under federal investigation for apparently mismanaging federal stem cell research grants. Also, a Johns Hopkins researcher also came under fire in December 2008 for trashing peer-reviewed research showing abortion’s link to negative mental health issues and problems for women. And the National Cancer Institute has been repeatedly blasted by pro-life advocates for denying the abortion-breast cancer link exists.
“Komen’s Parent Return for 2010 shows that millions of dollars in grants were given to research facilities that have policies supporting experiments on human embryos,” Malec says, adding that the list of schools is only a partial list of the facilities engaging in embryonic research that received grants.
Recent statements from the Catholic Bishop of Toledo, the Most Reverend Leonard Blair, bring up both abortion and the potential of Komen indirectly supporting embryonic research as reasons for Catholics to have misgivings about the breast cancer group. Malec says the statements from Bishop Blair “suggest that local Komen officials may have misled him and his associates with respect to the organization’s practices involving experiments on human embryos.”
“They are open to embryonic stem cell research and may well fund such research in the future,” the bishop noted.
Combined with the millions in donations to the nation’s biggest abortion business, Komen says the new information about the Komen ties to embryonic stem cell research centers makes it so the breast cancer group is not worthy of support. She says Komen needs to be honest with women about the abortion-breast cancer connection.
“It’s more than ironic that Planned Parenthood receives contributions from an organization allegedly dedicated to the eradication of breast cancer,” Malec says. “Abortion and the birth control pill – which Planned Parenthood sells – are risk factors for the disease. It’s certainly bad for business to tell women the truth about the abortion-breast cancer link. Knowledge of that risk would cause some to turn their backs on induced abortion and cut into Planned Parenthood’s profits.”
“On the other hand, warning women about the breast cancer risk of abortion would mean fewer breast cancer patients and, therefore, a reduction in donations for Komen. Telling donors that their previous abortions may have been responsible for their breast cancers is simply not a good fundraising tactic,” she concludes.